Le Lézard
Classified in: Health
Subjects: AWD, NPT, REL, AVO

As War in Israel Continues to Rage, The International Fellowship of Christians and Jews Approves $5 Million Emergency Grant


CHICAGO, Oct. 19, 2023 /PRNewswire/ -- As Israel's war with Hamas continues to intensify, the International Fellowship of Christians and Jews (The Fellowship) announced this week the immediate release of 20 million shekels (more than $5 million) to be distributed to support those in need.

Since the war began, The Fellowship has been actively working with partner organizations, the IDF Homefront Command, local municipalities, hospitals, and others to identify immediate, specific needs, and to ensure that funds are properly distributed.

On Sunday, The Fellowship announced:

"We are living through one of the worst tragedies ever to impact the state of Israel. We have witnessed a horrific attack on Israeli children, adults, the elderly ? innocent people who were murdered and never had the chance to defend themselves," said Yael Eckstein, President and CEO of The Fellowship.

"This attack has impacted every Israeli and has left countless people without a safe home to return to, and without access to basic supplies like food, medication, and clothing. Since the outbreak of the war, we have been working to respond in all ways possible. The Fellowship pledges to continue to respond to this emergency quickly and effectively, by offering our full support to people in need. We pray this horrific war will end soon, so we can focus on helping people rebuild their lives."

About the International Fellowship of Christians and Jews
For 40 years, the International Fellowship of Christians and Jews (The Fellowship) has been leading efforts to build bridges between Christians and Jews and provide humanitarian care and lifesaving aid for Israel and the Jewish people. Through the generosity and loyalty each year of its donors, partners, and staff, The Fellowship helps over 1 million people living in poverty, has provided nearly 3,000 bomb shelters for security, and has helped 770,000 make aliyah back to their homeland, Israel. The Fellowship celebrates its 40th anniversary this year, continuing a mission to bless Israel and the Jewish people ? like our world has never seen.

About Yael Eckstein
As President and CEO of The Fellowship, Yael Eckstein oversees all programs and serves as the international spokesperson for the organization. With over a decade of non-profit experience in multiple roles, Yael has the rare distinction of being a woman leading one of the world's largest religious charitable organizations. In addition to her podcast exploring the Jewish roots of the Christian faith, Nourish Your Biblical Roots. Yael also invites thought-leaders, pastors, authors, and other influencers to discuss Israel and Jewish-Christian relations on Conversations with Yael. She is the 2023 recipient of the Jerusalem Post's Humanitarian Award, and in 2020, 2021 and 2023, was named to the publication's list of 50 Most Influential Jews. Born outside of Chicago, Yael is based in Israel with her husband and their four children.

Media Contact: 
Elizabeth Gartman
[email protected]
+1 312-641-8544

SOURCE International Fellowship of Christians and Jews


These press releases may also interest you

at 00:25
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

19 mai 2024
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

19 mai 2024
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...



News published on and distributed by: